Former FDA attorneys say the Supreme Court’s recent decision to overturn Chevron deference, a decades-old legal precedent, could stall the development of new drugs and medical devices, Politico reported July 1.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
